logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Dae Young Zang

Hallym University Sacred Heart Hospital
H指数:36
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

更正：一项多中心 Ib/II 期研究，评估度鲁木单抗和 Tremelimumab 联合多西他赛在生物标志物选择的转移性胃癌患者中的二线治疗。

British Journal of Cancer
IF6.8
2025-11-110
PRE
Keun-Wook Lee; Dae Young Zang; Hyung-Don Kim; Jin-Won Kim; Bum Jun Kim; Yoon-Koo Kang; Min-Hee Ryu; Hark Kyun Kim
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09
BMC CANCER
IF3.4
2024-05-092
OAAI
Kim, Sun Young; Kim, Jee Hyun; Kim, Tae-Yong; Park, Sook Ryun; Yoon, Shinkyo; Lee, Soohyeon; Lee, Se-Hoon; Kim, Tae Min; Han, Sae-Won; Kim, Hye Ryun; Yun, Hongseok; Lee, Sejoon; Kim, Jihun; Choi, Yoon-La; Choi, Kui Son; Chae, Heejung; Ryu, Hyewon; Lee, Gyeong-Won; Zang, Dae Young; Ahn, Joong Bae
Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OA
Kim, T-Y.; Kim, S. Y.; Kim, J. H.; Jung, H. A.; Choi, Y. J.; Hwang, I. G.; Cha, Y.; Lee, G-W.; Lee, Y-G.; Kim, T. M.; Lee, S-H.; Lee, S.; Yun, H.; Choi, Y-L.; Yoon, S.; Han, S-W.; Kim, T-Y.; Kim, T. W.; Zang, D. Y.; Kang, J. H.
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer

一线pembrolizumab，曲妥珠单抗和化疗治疗晚期HER2-positive胃癌的单臂Ib/II期试验

NATURE COMMUNICATIONS
IF15.7
2022-10-1223
OAAI
Lee, Choong-kun; Rha, Sun Young; Kim, Hyo Song; Jung, Minkyu; Kang, Beodeul; Che, Jingmin; Kwon, Woo Sun; Park, Sejung; Bae, Woo Kyun; Koo, Dong-Hoe; Shin, Su-Jin; Kim, Hyunki; Jeung, Hei-Cheul; Zang, Dae Young; Lee, Sang Kil; Nam, Chung Mo; Chung, Hyun Cheol
PWWP2B promotes DNA end resection and homologous recombination

PWWP2B促进DNA末端切除和同源重组

EMBO REPORTS
IF6.2
2022-05-183
OA
Ju, Min Kyung; Lee, Joo Rak; Choi, Yeonsong; Park, Seon Young; Sul, Hee Jung; Chung, Hee Jin; An, Soyeong; Lee, Semin; Jung, Eunyoung; Kim, Bohyun; Choi, Bo Youn; Kim, Bum Jun; Kim, Hyeong Su; Lim, Hyun; Kang, Ho Suk; Soh, Jae Seung; Myung, Kyungjae; Kim, Kab Choong; Cho, Ji Woong; Seo, Jinwon; Kim, Tae Moon; Lee, Ja Yil; Kim, Yonghwan; Kim, Hongtae; Zang, Dae Young
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)

Ramucirumab联合紫杉醇作为HER2-positive胃癌的二线治疗: 韩国一项全国性真实世界研究的亚组分析 (KCSG-ST19-16)

GASTRIC CANCER
IF5.1
2022-01-114
OA
Kim, Bum Jun; Jee, Hee-Jung; Rha, Sun Young; Han, Hye Sook; Ryu, Min-Hee; Park, Se Hoon; Kim, Jong Gwang; Bae, Woo Kyun; Lee, Keun-Wook; Oh, Do-Youn; Byun, Ji-Hye; Kim, Dong Sook; Suh, Young Ju; An, Hyonggin; Zang, Dae Young

研究方向

暂未获取到该数据
H
Hyeong Su Kim
H 指数:29论文数:142被引数:2,816
B
Bum Jun Kim
H 指数:22论文数:87被引数:2,382
M
Min‐Hee Ryu
H 指数:60论文数:522被引数:2.0万
S
Sun Young Rha
H 指数:86论文数:1,323被引数:3.4万
I
In Gyu Hwang
H 指数:32论文数:207被引数:4,216
B
Boram Han
H 指数:18论文数:86被引数:1,209
J
Jung Han Kim
H 指数:36论文数:195被引数:4,486
K
Keun‐Wook Lee
H 指数:55论文数:483被引数:1.5万
H
Hee Jung Sul
H 指数:8论文数:25被引数:152
D
Dae Ro Choi
H 指数:16论文数:62被引数:716